Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11918685 Amlodipine formulations

Patent 11918685 was granted and assigned to Azurity Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Azurity Pharmaceuticals

0

Current Assignee

Azurity Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Gerold L. Mosher0

Scott Brauer0

Date of Patent

March 5, 2024

0

Patent Application Number

182032660

Date Filed

May 30, 2023

0

Patent Citations

US Patent 7772400 Optical resolution method of amlodipine

0

US Patent 8158146 Stable combinations of amlodipine besylate and benazepril hydrochloride

0

US Patent 8377994 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions

0

US Patent 10695329 Amlodipine formulations

0

US Patent 10799453 Amlodipine formulations

0

US Patent 10894039 Amlodipine formulations

0

US Patent 10952998 Amlodipine formulations

0

US Patent 10959991 Amlodipine formulations

0

...

Patent Citations Received

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

Patent abstract

Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11918685 Amlodipine formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.